Merus (MRUS) Announces Publication of an Abstract on Petosemtamab with Pembrolizumab as 1L treatment of r/m HNSCC at the 2024 ASCO Annual Meeting

Visit StreetInsider.com at http://www.streetinsider.com/Momentum+Movers/Merus+%28MRUS%29+Announces+Publication+of+an+Abstract+on+Petosemtamab+with+Pembrolizumab+as+1L+treatment+of+rm+HNSCC+at+the+2024+ASCO+Annual+Meeting/23274129.html for the full story.